<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="20/03/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8108414">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8108414</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Autoregulation of the <term sem="Protein_family_or_group" id="T1" lex="NF-kappa_B_transactivator"><term sem="Protein_complex" id="T2" lex="NF-kappa_B">NF-kappa B</term> transactivator</term> <term sem="Protein_molecule" id="T3" lex="RelA">RelA</term> (<term sem="Protein_molecule" id="T4" lex="p65">p65</term>) by multiple <term sem="Protein_family_or_group" id="T5" lex="cytoplasmic_inhibitor">cytoplasmic inhibitors</term> containing <term sem="Protein_substructure" id="T6" lex="ankyrin_motif">ankyrin motifs</term>.</sentence>
<event id="E50">
<type class="Regulation" />
<theme idref="T4" />
<cause idref="T5" />
<clue><clueType>Autoregulation</clueType> <linkTheme>of</linkTheme> the NF-kappa B transactivator RelA (p65) <linkCause>by</linkCause> multiple cytoplasmic inhibitors containing ankyrin motifs.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T7" lex="RelA">RelA</term> (<term sem="Protein_molecule" id="T8" lex="p65">p65</term>) functions as the critical transactivating component of the <term sem="Protein_complex" id="T9" lex="heterodimeric_p50-p65_NF-kappa_B_complex">heterodimeric p50-<term sem="Protein_molecule" id="T10" lex="p65">p65</term> <term sem="Protein_complex" id="T11" lex="NF-kappa_B">NF-kappa B</term> complex</term> and contains a <term sem="Protein_domain_or_region" id="T12" lex="high-affinity_binding_site">high-affinity binding site</term> for its <term sem="Protein_family_or_group" id="T13" lex="cytoplasmic_inhibitor">cytoplasmic inhibitor</term>, <term sem="Protein_molecule" id="T14" lex="I_kappa_B_alpha">I kappa B alpha</term>.</sentence>
<sentence id="S3">After <term sem="Other" id="A1">cellular activation</term>, <term sem="Protein_molecule" id="T15" lex="I_kappa_B_alpha">I kappa B alpha</term> is rapidly degraded in concert with the induced nuclear translocation of <term sem="Protein_complex" id="T16" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E1">
<type class="Protein_catabolism" />
<theme idref="T15" />
<clue>After cellular activation, I kappa B alpha is rapidly <clueType>degraded</clueType> in concert with the induced nuclear translocation of NF-kappa B.</clue>
</event>
<event id="E51">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue><linkCause>After</linkCause> cellular activation, I kappa B alpha is rapidly degraded in concert with the induced nuclear translocation of NF-kappa B.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E2">
<type class="Localization" />
<theme idref="T16" />
<clue>After cellular activation, I kappa B alpha is rapidly degraded in concert with the induced <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="E2" />
<cause idref="A1" />
<clue>After cellular activation, I kappa B alpha is rapidly degraded in concert with the <clueType>induced</clueType> nuclear translocation of NF-kappa B.</clue>
</event>
<sentence id="S4">The present study demonstrates that <term sem="Other" id="T17" lex="tumor_necrosis_factor_alpha-induced_degradation"><term sem="Protein_molecule" id="T18" lex="tumor_necrosis_factor_alpha">tumor necrosis factor alpha</term>-induced degradation</term> of <term sem="Protein_molecule" id="T19" lex="I_kappa_B_alpha">I kappa B alpha</term> in <term sem="Cell_natural" id="T20" lex="human_T_cell">human T cells</term> is preceded by its rapid phosphorylation in vivo.</sentence>
<event id="E104">
<type class="Protein_catabolism" />
<theme idref="T19" />
<clue>The present study demonstrates that tumor necrosis factor alpha-induced <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha in human T cells is preceded by its rapid phosphorylation in vivo.</clue>
</event>
<event id="E105">
<type class="Positive_regulation" />
<theme idref="E104" />
<cause idref="T18" />
<clue>The present study demonstrates that tumor necrosis factor alpha-<clueType>induced</clueType> degradation of I kappa B alpha <clueLoc>in human T cells</clueLoc> is preceded by its rapid phosphorylation in vivo.</clue>
</event>
<event id="E5">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T19" />
<clue>The present study demonstrates that tumor necrosis factor alpha-induced degradation of I kappa B alpha in human T cells is preceded by <corefTheme>its</corefTheme> rapid <clueType>phosphorylation</clueType> in vivo.</clue>
</event>
<event id="E6">
<type class="Correlation" />
<theme idref="E105" />
<theme idref="E5" />
<clue>The present study demonstrates that tumor necrosis factor alpha-induced degradation of I kappa B alpha in human T cells is <clueType>preceded</clueType> <linkTheme>by</linkTheme> its rapid phosphorylation in vivo.</clue>
</event>
<sentence id="S5">However, these effects on <term sem="Protein_molecule" id="T21" lex="I_kappa_B_alpha">I kappa B alpha</term> result in nuclear mobilization of only a fraction of the entire <term sem="Other" id="T22" lex="cytoplasmic_pool">cytoplasmic pool</term> of <term sem="Protein_molecule" id="T23" lex="RelA">RelA</term>.</sentence>
<event id="E7">
<type class="Localization" />
<theme idref="T23" />
<clue>However, these effects on I kappa B alpha result in <clueLoc>nuclear</clueLoc> <clueType>mobilization</clueType> <linkTheme>of</linkTheme> only a fraction of the entire cytoplasmic pool of RelA.</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="E105" />
<clue>However, <corefCause>these effects</corefCause> on I kappa B alpha <clueType>result in</clueType> nuclear mobilization of only a fraction of the entire cytoplasmic pool of RelA.</clue>
</event>
<sentence id="S6">Subsequent studies have revealed that (i) <term sem="Protein_molecule" id="T24" lex="cytoplasmic_RelA">cytoplasmic <term sem="Protein_molecule" id="T25" lex="RelA">RelA</term></term> is stably associated not only with <term sem="Protein_molecule" id="T26" lex="I_kappa_B_alpha">I kappa B alpha</term> but also with other <term sem="Protein_family_or_group" id="T27" lex="ankyrin_motif-rich_protein">ankyrin motif-rich proteins</term> including the products of the <cons sem="(AND DNA_domain_or_region DNA_domain_or_region)" id="T28" lex="(AND NF-kappa_B2_(p100)_genes NF-kappa_B1_(p105)_genes)"><frag id="F1">NF-kappa B2 (<term sem="Protein_molecule" id="A20">p100</term>)</frag> and <frag id="F2">NF-kappa B1 (<term sem="Protein_molecule" id="A21">p105</term>)</frag> <frag id="F3">genes</frag></cons>; (ii) in contrast to <term sem="Protein_molecule" id="T29" lex="RelA">RelA</term><term sem="Protein_molecule" id="T30" lex="I_kappa_B_alpha">-I kappa B alpha</term>, <term sem="Protein_complex" id="T31" lex="RelA-p100_cytoplasmic_complex"><term sem="Protein_molecule" id="T32" lex="RelA">RelA</term>-<term sem="Protein_molecule" id="A50">p100</term> cytoplasmic complexes</term> are not dissociated following <term sem="Protein_molecule" id="T33" lex="tumor_necrosis_factor_alpha">tumor necrosis factor alpha</term> activation; (iii) <term sem="Protein_molecule" id="T34" lex="p100">p100</term> functions as a potent inhibitor of <term sem="Other" id="T35" lex="RelA-mediated_transcription"><term sem="Protein_molecule" id="T36" lex="RelA">RelA</term>-mediated <term sem="Other" id="A31">transcription</term></term> in vivo; (iv) the interaction of <term sem="Protein_molecule" id="T37" lex="RelA">RelA</term> and <term sem="Protein_molecule" id="T38" lex="p100">p100</term> involves the <term sem="Protein_domain_or_region" id="T39" lex="conserved_Rel_homology_domain">conserved Rel homology domain</term> of both proteins but not the <term sem="Protein_domain_or_region" id="T40" lex="nuclear_localization_signal">nuclear localization signal</term> of <term sem="Protein_molecule" id="T41" lex="RelA">RelA</term>, which is required for <term sem="Other" id="T42" lex="I_kappa_B_alpha_binding"><term sem="Protein_molecule" id="T43" lex="I_kappa_B_alpha">I kappa B alpha</term> binding</term>; (v) <term sem="Protein_molecule" id="T44" lex="p100">p100</term> inhibition of <term sem="Protein_molecule" id="T45" lex="RelA">RelA</term> function requires the <term sem="Protein_domain_or_region" id="T46" lex="C-terminal_ankyrin_motif_domain">C-terminal ankyrin motif domain</term>, which mediates cytoplasmic retention of <term sem="Protein_molecule" id="T47" lex="RelA">RelA</term>; and (vi) as observed with <term sem="Protein_molecule" id="T48" lex="I_kappa_B_alpha">I kappa B alpha</term>, nuclear <term sem="Protein_molecule" id="T49" lex="RelA">RelA</term> stimulates <term sem="RNA_molecule" id="T50" lex="p100_mRNA"><term sem="Protein_molecule" id="T51" lex="p100">p100</term> mRNA</term> and <term sem="Other" id="T52" lex="protein_expression"><term sem="Protein_molecule" id="A25">protein</term> expression</term>.</sentence>
<event id="E9">
<type class="Binding" />
<theme idref="T25" />
<theme idref="T26" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably <clueType>associated</clueType> not only <linkTheme>with</linkTheme> I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E19">
<type class="Binding" />
<theme idref="T25" />
<theme idref="A20" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably <clueType>associated</clueType> not only with I kappa B alpha but also <linkTheme>with</linkTheme> other <corefTheme idref1="A20">ankyrin motif-rich proteins</corefTheme> including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E30">
<type class="Binding" />
<theme idref="T25" />
<theme idref="A21" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably <clueType>associated</clueType> not only with I kappa B alpha but also <linkTheme>with</linkTheme> other <corefTheme idref1="A21">ankyrin motif-rich proteins</corefTheme> including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E31">
<type class="Binding" />
<theme idref="T25" />
<theme idref="T27" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably <clueType>associated</clueType> not only with I kappa B alpha but also <linkTheme>with</linkTheme> other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E113">
<type />
<theme idref="T29" />
<theme idref="T30" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not <clueType>dissociated</clueType> <linkCause>following</linkCause> tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
<comment>SOO</comment>
</event>
<event id="E114">
<type />
<theme idref="T32" />
<theme idref="A50" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not <clueType>dissociated</clueType> following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
<comment>SOO</comment>
</event>
<event id="E115">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref="T33" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha <clueType>activation</clueType>; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E116">
<type class="Positive_regulation" />
<theme idref="E113" />
<cause idref="E115" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated <linkCause>following</linkCause> tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event assertion="non-exist" id="E117">
<type class="Positive_regulation" />
<theme idref="E114" />
<cause idref="E115" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated <linkCause>following</linkCause> tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event uncertainty="probable" id="E71">
<type class="Positive_regulation" />
<theme idref="A31" />
<cause idref="T36" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-<clueType>mediated</clueType> transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event uncertainty="probable" id="E15">
<type class="Negative_regulation" />
<theme idref="E71" />
<cause idref="T34" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E16">
<type class="Binding" />
<theme idref="T44" />
<theme idref="T45" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the <clueType>interaction</clueType> <linkTheme>of</linkTheme> RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E17">
<type class="Correlation" />
<theme idref="E16" />
<theme idref="T39" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 <clueType>involves</clueType> the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event assertion="non-exist" id="E18">
<type class="Correlation" />
<theme idref="E16" />
<theme idref="T40" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 <clueType>involves</clueType> the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E32">
<type class="Binding" />
<theme idref="T41" />
<theme idref="T43" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha <clueType>binding</clueType>; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="E32" />
<cause idref="T40" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is <clueType>required</clueType> <linkTheme>for</linkTheme> I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="T45" />
<cause idref="T44" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 <clueType>inhibition</clueType> <linkTheme>of</linkTheme> RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E20" />
<cause idref="T46" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function <clueType>requires</clueType> the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E60">
<type class="Localization" />
<theme idref="T47" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates <clueLoc>cytoplasmic</clueLoc> <clueType>retention</clueType> <linkTheme>of</linkTheme> RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E61">
<type class="Positive_regulation" />
<theme idref="E60" />
<cause idref="T46" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which <clueType>mediates</clueType> cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.</clue>
</event>
<event id="E22">
<type class="Transcription" />
<theme idref="T50" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein <clueType>expression</clueType>.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="E22" />
<cause idref="T49" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA <clueType>stimulates</clueType> p100 mRNA and protein expression.</clue>
</event>
<event id="E34">
<type class="Gene_expression" />
<theme idref1="A25" idref="T51" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein <clueType>expression</clueType>.</clue>
</event>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="E34" />
<cause idref="T49" />
<clue>Subsequent studies have revealed that (i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif-rich proteins including the products of the NF-kappa B2 (p100) and NF-kappa B1 (p105) genes; (ii) in contrast to RelA-I kappa B alpha, RelA-p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; (iii) p100 functions as a potent inhibitor of RelA-mediated transcription in vivo; (iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; (v) p100 inhibition of RelA function requires the C-terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and (vi) as observed with I kappa B alpha, nuclear RelA <clueType>stimulates</clueType> p100 mRNA and protein expression.</clue>
</event>
<sentence id="S7">These findings thus reveal the presence of a second <term sem="Other" id="T53" lex="inducible_autoregulated_inhibitory_pathway">inducible autoregulated inhibitory pathway</term> that helps ensure the rapid but transient action of <term sem="Protein_complex" id="T54" lex="nuclear_NF-kappa_B">nuclear <term sem="Protein_complex" id="T55" lex="NF-kappa_B">NF-kappa B</term></term>.</sentence>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
